NDC 0024-5745

ADLYXIN

Lixisenatide

ADLYXIN is a Kit in the Human Prescription Drug category. It is labeled and distributed by Sanofi-aventis U.s. Llc. The primary component is .

• Product ID: 0024-5745_46bfa5a6-3b18-46da-95d0-0a7ac6983cb1
• NDC: 0024-5745
• Product Type: Human Prescription Drug
• Proprietary Name: ADLYXIN
• Generic Name: Lixisenatide
• Dosage Form: Kit
• Marketing Start Date: 2016-07-27
• Marketing Category: BLA / NDA
• Application Number: BLA208471
• Labeler Name: sanofi-aventis U.S. LLC
• Active Ingredient Strength: 0
• NDC Exclude Flag: N
• Listing Certified Through: 2022-12-31

Packaging

NDC 0024-5745-02

1 KIT in 1 CARTON (0024-5745-02) * 3 mL in 1 SYRINGE (0024-5741-01) * 3 mL in 1 SYRINGE (0024-5740-00)

• Marketing Start Date: 2016-07-27
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 0024-5745-02 [00024574502]

ADLYXIN KIT

• Marketing Category: BLA
• Application Number: BLA208471
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 2016-07-27

Drug Details

OpenFDA Data

• SPL SET ID: 1727cc16-4f86-4f13-b8b5-804d4984fa8c
• Manufacturer:
  • Sanofi-Aventis U.S. LLC
• UNII:
  • 74O62BB01U
• RxNorm Concept Unique ID - RxCUI:
  • 1803894
  • 1803896
  • 1803902
  • 1803903
  • 1803892
  • 1803893

NDC Crossover Matching brand name "ADLYXIN" or generic name "Lixisenatide"

NDC	Brand Name	Generic Name
0024-5745	ADLYXIN	Lixisenatide
0024-5747	ADLYXIN	Lixisenatide